Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetesThomas Blevins, John Pullman, Jaret Malloy, et al.
Lancet (London, England)|September 11, 2008
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority studyDaniel J Drucker, John B Buse, Kristin Taylor, et al.
British Journal of Clinical Pharmacology|August 14, 2012
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjectsBörje Darpö, Philip Sager, Leigh MacConell, et al.
Molecular Autism|February 12, 2019
Sensory over-responsivity: parent report, direct assessment measures, and neural architectureTeresa Tavassoli, Anne Brandes-Aitken, Robyn Chu, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2021
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric HypoglycemiaColleen M Craig, Helen Margaret Lawler, Clare Jung Eun Lee, et al.
Lancet (London, England)|November 13, 2012
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studyJohn B Buse, Michael Nauck, Thomas Forst, et al.
Pageof 2